The core message

During and immediately after a mass emergency, societies often enter a “panic and neglect” cycle: invest heavily amid crisis, then let systems erode when the threat appears to recede. Michael Osterholm’s warning, highlighted by Live Science, is that this cycle has once again taken hold. The public health, clinical, industrial, and data infrastructures that enabled a partial—if imperfect—response to COVID‑19 have been scaled back, politicized, or allowed to lapse. The result is a thinner margin of safety against future threats, whether a new coronavirus variant, an influenza pandemic, a novel zoonotic spillover, or antimicrobial-resistant outbreaks.

What “pandemic capacity” actually entails

Pandemic capacity is not a single program or warehouse. It is an ecosystem with interlocking parts:

• Detection and surveillance: Clinical testing, sentinel networks, wastewater monitoring, and genomic sequencing that can spot unusual patterns early and track pathogen evolution.
• Public health workforce: Trained epidemiologists, data analysts, contact tracers, community health workers, laboratorians, and risk communicators embedded across jurisdictions.
• Healthcare surge: Hospital and clinic ability to expand beds and staffing, maintain adequate oxygen, ICU capacity, and reliable supply of critical consumables.
• Medical countermeasures: Rapid R&D, manufacturing, procurement, and equitable distribution of vaccines, therapeutics, diagnostics, and PPE.
• Supply chains: Diversified, transparent, and resilient production and logistics for everything from swabs to filters to generic drugs.
• Data systems: Timely, standardized, interoperable data flows from providers and labs to local, state, and national public health authorities, with analytics to inform action.
• Risk communication and trust: Clear, credible, and adaptive messaging that helps the public make sense of uncertainty and change behavior when needed.
• Legal and governance tools: Public health authority to act quickly and proportionately, with oversight and transparency, and mechanisms for interstate and international coordination.
• Community partnerships and equity: Relationships with schools, employers, faith groups, and local leaders to ensure responses reach and protect those at highest risk.

When any of these pillars weakens, the entire system becomes brittle. When several degrade at once, even modest shocks can cascade into crises.

Where and how capacity has eroded

Since the acute phases of COVID‑19, multiple stress fractures have appeared:

• Workforce attrition and burnout: Thousands of state and local public health professionals resigned or retired. Hiring pipelines and training budgets have not kept pace with losses.
• Reduced surveillance sensitivity: Routine PCR testing has plummeted; many dashboards were sunset; genomic sequencing volumes declined; and wastewater monitoring, while valuable, is unevenly funded and adopted.
• Shortened institutional memory: Emergency operations centers scaled down; incident command expertise dispersed; after-action findings were not always translated into durable reforms.
• PPE and supply instability: Domestic manufacturing lines for respirators, swabs, and other supplies ramped up during the crisis but many shut down when demand and purchasing guarantees evaporated.
• Data fragmentation: Interoperability projects advanced, but reporting variability across jurisdictions persists, creating blind spots and delaying situational awareness.
• Legal constraints and politicization: In several jurisdictions, new laws narrowed public health authorities’ ability to issue time-sensitive interventions, while political polarization eroded compliance and trust.
• Complacency in ventilation and indoor air quality: Many temporary fixes were removed; long-term standards and investments in schools, workplaces, and long-term care facilities remain inconsistent.
• Stalled countermeasure momentum: Investment in next-generation vaccines (e.g., pan-variant, intranasal/mucosal) and broadly acting antivirals has not matched the urgency of 2020–2021.

These trends do not mean we are helpless. But they lengthen response times, increase uncertainty, and raise the human and economic cost of the next outbreak.

Why this matters even if “COVID is milder now”

It is tempting to treat a lull as an endpoint. Yet biological risk is dynamic. Viruses evolve; influenza continues to reassort; animal–human interfaces expand; climate pressures shift disease ranges; and antimicrobial resistance grows. Preparedness is insurance: it looks expensive until you compare it to the cost of uncontrolled spread, health system saturation, supply chain breakdowns, and long-term morbidity like post-viral syndromes.

Moreover, capacity built for respiratory pandemics delivers broad benefits: better indoor air reduces absenteeism; modernized data systems improve routine immunization and chronic disease management; resilient supply chains cushion against natural disasters and geopolitical shocks.

Key lessons we must not unlearn

• Speed beats perfection: Early, adaptable action averts exponential harm. Systems should favor rapid, revisable decisions over delayed consensus.
• Layered risk reduction works: Vaccination, ventilation, high-quality masks, and targeted therapeutics complement each other; no single tool is sufficient alone.
• Communication is a core intervention: Uncertainty must be acknowledged, guidance must update transparently, and messengers should be trusted community figures as well as officials.
• Equity is effectiveness: Outbreaks exploit inequities. Ensuring access in underserved communities reduces overall transmission and mortality.
• Domestic manufacturing matters: Just-in-time global supply chains fail under synchronized global demand. Strategic domestic and allied capacity is essential.
• Indoor air is public health infrastructure: Standards for ventilation and filtration can make shared spaces safer against many pathogens.

A practical roadmap to rebuild capacity

An actionable agenda can be pursued now, at federal, state, and local levels, and by private sector and civil society partners.

1) Stabilize and grow the public health workforce

• Create multi-year, baseline-funded positions rather than time-limited emergency hires.
• Invest in field epidemiology training, data science, risk communication, and community health worker programs.
• Establish surge staffing registries that can activate across states with pre-arranged credentials.

2) Modernize surveillance for speed and granularity

• Maintain wastewater networks with standardized methods and public dashboards.
• Guarantee sequencing capacity and representative sampling to track variants and other pathogens.
• Integrate clinical, lab, pharmacy, and syndromic data with privacy-preserving, interoperable standards.

3) Make indoor air quality a permanent priority

• Adopt updated ventilation and filtration targets in building codes and school facility standards.
• Fund retrofits (e.g., MERV‑13/HEPA, CO₂ monitoring) in high-risk settings like schools, long-term care, and public transit.
• Promote procurement of reusable elastomeric respirators for healthcare surge and critical infrastructure.

4) Secure resilient supply chains

• Use advance market commitments and long-term contracts to sustain domestic PPE, diagnostic, and essential drug manufacturing.
• Diversify suppliers and create visibility into inventories for critical consumables and active pharmaceutical ingredients.
• Regularly audit and rotate national and regional stockpiles to prevent obsolescence.

5) Accelerate medical countermeasure R&D

• Invest in broadly protective and mucosal vaccines; pan-sarbecovirus and universal influenza candidates.
• Develop host-targeted and variant-resilient antivirals, and rapid antigen platforms adaptable to new threats.
• Support “prototype pathogen” programs and the 100‑day mission to compress development timelines.

6) Strengthen healthcare surge and safety

• Fund flexible ICU capacity, oxygen systems, and staffing models that can scale under stress.
• Institutionalize respiratory protection programs and fit-testing in healthcare and long-term care.
• Build cross-state compacts for rapid credentialing and deployment of clinicians during emergencies.

7) Restore trust through transparent communication

• Publish clear triggers for public health actions and the evidence behind them.
• Partner with local leaders, schools, employers, and faith organizations to co-create messages.
• Confront mis- and disinformation with consistent, empathetic, and evidence-based outreach.

8) Protect and clarify public health authority

• Review legal frameworks to ensure proportionate, time-limited, accountable tools remain available for emergencies.
• Embed civil liberties safeguards and transparent oversight to maintain public confidence.

9) Measure what matters and hold ourselves accountable

• Track readiness metrics: time-to-detection, sequencing turnaround, stockpile adequacy, ventilation compliance, workforce capacity.
• Conduct regular exercises and publish after-action reports with timelines for remediation.

10) Engage globally

• Support surveillance, laboratory, and manufacturing capacity in low- and middle-income countries.
• Advance equitable access frameworks so countermeasures reach those at risk when it matters most.
• Coordinate on standards, data sharing, and supply chain resilience with allies and international bodies.

Common objections, addressed

“We can’t afford this.”

The costs of sustained preparedness are a fraction of pandemic losses measured in lives, long-term disability, learning gaps, and trillions of dollars of economic disruption. Investments in air quality, data, and manufacturing deliver everyday dividends beyond pandemics.

“We overreacted last time; let’s not repeat that.”

The goal is not to replicate blunt early measures but to build precision: detect sooner, target smarter, protect the most vulnerable, maintain essential services, and keep schools and businesses safer and open. Better capacity reduces the need for disruptive interventions.

“People won’t comply anyway.”

Compliance improves when guidance is clear, consistent, proportionate, and locally voiced. Trust is an outcome of sustained relationships, transparency, and demonstrated competence—things capacity-building directly supports.

The window before the next crisis

The period between emergencies is when real preparedness is built. That means converting emergency appropriations into durable baselines, codifying successful innovations, and fixing what failed. It also means resisting the urge to declare premature victory or accept attrition as inevitable. The science, technologies, and playbooks we need exist; what is required now is focus, funding stability, and leadership.

Michael Osterholm’s warning should be taken not as fatalism but as an actionable diagnosis. Capacity is not a static asset; it is a living system that weakens without care and strengthens with use. Rebuilding it—surveillance that sees, data that moves, air that is cleaner, supply chains that hold, authorities that act, and communities that trust—is both possible and urgent.